Jay Schlaifer is a Cardiology physician. OpenAlex indexes 13 publications with 214 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3900 St Francis Way Ste 205
Lafayette, IN 479054939
Telephone
765-428-2500Provider last certified this registry record 15 Aug 2022.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20253 payments
- ASAHI INTECC USA, INC.Program year20251 payment
- Abbott LaboratoriesProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.6%Beta blocker16.1%Metoprolol Succinate43%Metoprolol Tartrate27%Carvedilol24%Atenolol5%Sotalol2%Part D<11 patientsStatin15.7%Atorvastatin Calcium60%Rosuvastatin Calcium32%Pravastatin Sodium4%Simvastatin4%Part D≥194 patients+ 23 more classes in this area
Blood & clotting
13.8%Factor Xa inhibitor7.8%Eliquis69%Xarelto31%Part D≥91 patientsP2Y12 inhibitor5.5%Clopidogrel94%Brilinta6%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.6%SGLT2 inhibitor2.6%Jardiance66%Farxiga34%Part D≥37 patientsPotassium supplement2.3%Potassium Chloride90%Klor-Con M2010%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of low molecular weight heparin on coronary endothelial function in acute cellular heart transplant rejection
The American Journal of Cardiology
2000 - Influence of Smoking Status on Angiotensin-Converting Enzyme Inhibition–Related Improvement in Coronary Endothelial Function
Cardiovascular Drugs and Therapy
1999
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”